Retinal Imaging for Dementia and Neurodegenerative Diseases
Retinal Hyperspectral Imaging in Neurodegenerative Diseases
Recruiting
N/A
Interventional Study
Dementia
Neurodegenerative Diseases
Alzheimer Disease
Parkinson Disease
Frontotemporal Dementia
Vascular Dementia
Lewy Body Disease
Niemann-Pick Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 30 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 930 (estimated)
- Sponsor
- Center for Eye Research Australia · Other
Who this trial is looking for
This trial is looking for adults over 30 with dementia or a related disease. Participants will have special eye imaging done to help researchers understand more about these conditions.
Are You a Good Fit for This Trial?
You may be able to join if
- I am over 30 years old
- I have been diagnosed with dementia or a neurodegenerative disease
- I have had tests like genetic or blood biomarker tests to confirm my diagnosis
- I can see well enough with my best correction to achieve 6/60 vision in both eyes
- I am willing to participate and visit the Centre for Eye Research Australia
- I will be accompanied by a friend or family member
You may not be able to join if
- I cannot provide informed consent
- I have eye conditions that prevent proper imaging
- I have a known issue with pupil dilation
- I have a health condition that could affect my safety or imaging quality
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
Hyperspectral retinal imaging is a non-invasive imaging modality in which a series of images of the retina are captured using light of different wavelengths. The resulting "hypercube" of data provides a wealth of information about the retinal structure. Our group has developed evidence supporting a role for this technology in the detection of retinal amyloid beta in Alzheimer's disease. We are und…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Aged over 30 years.
2. Have dementia or a neurodegenerative disease such as Alzheimer's disease, Parkinson's disease, Lewy body dementia, Niemann-Pick type 2 or vascular dementia (age-matched and sex-matched controls will also be recruited).
3. With the exception of participa…
Contacts